Latest News

More cases are probably coming July 24, 2017

At least one company might have attempted to settle but the Commonwealth is expected to pursue a number of other companies for compensation related to their actions delaying the entry of generics.

Supply chain delivered on HCV July 24, 2017

PBS wholesalers and Gilead have teamed up to hail the supply chain's ability to deliver for Australian patients.

Americans want action to protect innovation July 24, 2017

Americans want their government to use trade agreement to protect the intellectual property of the country's pharmaceutical industry.

Need to keep pace with more active consumer July 24, 2017

A more active consumer will be a key theme of the World Self Medication Industry conference to be held in Sydney in October.

MSD and Pfizer back Trump innovation plan July 24, 2017

Pfizer and MSD have teamed up with Corning to introduce a new glass packaging technology for medicines.

TPP11 discussions continue July 21, 2017

The 11 countries remaining in Trans Pacific Partnership have met in Japan to discuss options for advancing the agreement without the US.

Second year of Astellas C3 Prize July 21, 2017

The prize is part of a global challenge designed to change cancer care by inspiring non-medicine innovations that may improve the lives of patients with cancer, their caregivers and families.

AFT secures new deal for Maxigesic July 21, 2017

Australian-based AFT Pharmaceuticals has extended the global distribution of painkiller Maxigesic to now include over 120 countries.

New HCV therapy for PBS in August July 20, 2017

Gilead's EPLCUSA (sofosbuvir with velpatasvir) will be listed for the treatment of adults with all types of chronic hepatitis C infection (HCV).

First generics of popular pain therapy July 20, 2017

A raft of generics will be listed on the PBS on 1 August, triggering a statutory price reduction, price disclosure and fierce competition at pharmacy-level for a share of what is currently a $170 million product.

Quilty: Whole of sector challenge July 20, 2017

"If the King Review has done one favour for community pharmacy, it is to remind us all that we need to set our sights firmly on the future," according to Pharmacy Guild executive director David Quilty.

UniQuest seals long-term deal to tackle diabetes and obesity July 20, 2017

A potential gene therapy to treat diabetes and obesity is the subject of a third research and option agreement announced between Canadian health company PreveCeutical Medical and The University of Queensland’s main commercialisation company UniQuest.

Most Read

More cases are probably coming

MSD and Pfizer back Trump innovation plan

Supply chain delivered on HCV

Need to keep pace with more active consumer

Americans want action to protect innovation

New Stories

More cases are probably coming

Supply chain delivered on HCV

Americans want action to protect innovation

Need to keep pace with more active consumer

MSD and Pfizer back Trump innovation plan

Another senior official leaves pharmaceutical benefits

TPP11 discussions continue

Sign In

Most Read

More cases are probably coming

MSD and Pfizer back Trump innovation plan

Supply chain delivered on HCV

Need to keep pace with more active consumer

Americans want action to protect innovation

Follow Us

New Stories

More cases are probably coming

Supply chain delivered on HCV

Americans want action to protect innovation

Need to keep pace with more active consumer

MSD and Pfizer back Trump innovation plan

Another senior official leaves pharmaceutical benefits

TPP11 discussions continue